A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.

A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.

Item
http://www.wikidata.org/entity/Q39723933
A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor ActivityGenetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancerSimultaneous determination of lidamycin enediyne chromophore (LDC) and its aromatized derivative (LDCA) using puerarin as internal standard in rat plasma by LC-MS/MS.Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.An EGFR/HER2-Bispecific and enediyne-energized fusion protein shows high efficacy against esophageal cancer.Site-specific PEGylation of lidamycin and its antitumor activity.An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy.Small antibody fusion proteins with complementarity-determining regions and lidamycin for tumor targeting therapyTissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma.EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells.A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma.Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.A novel enediyne-integrated antibody-drug conjugate shows promising anti-tumor efficacy against CD30+ lymphomas.An arginine-rich cell penetrating peptide contained anti-gelatinase scFv-LDM fusion protein shows potent antitumor efficacy in pancreatic cancer.An arginine-rich cell penetrating peptide contained anti-gelatinase scFv-LDM fusion protein shows potent antitumor efficacy in pancreatic cancer.
P2860

A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.

Item
http://www.wikidata.org/entity/Q39723933
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A bispecific enediyne-energize ...... ows potent antitumor activity.
@en
A bispecific enediyne-energize ...... ows potent antitumor activity.
@nl
type
label
A bispecific enediyne-energize ...... ows potent antitumor activity.
@en
A bispecific enediyne-energize ...... ows potent antitumor activity.
@nl
prefLabel
A bispecific enediyne-energize ...... ows potent antitumor activity.
@en
A bispecific enediyne-energize ...... ows potent antitumor activity.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
A bispecific enediyne-energize ...... ows potent antitumor activity.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-09-2699
P407
P433
P478
P577
P698